Eugene Investment & Securities projected EasyBio's second-quarter revenue and operating profit to reach 112.1 billion won and 10.2 billion won, respectively. This represents year-on-year growth of 11% and 20%. Researcher Heo Junseo stated, "The impact of acquisitions ended after the first quarter, so topline growth has slowed. However, the end of retention bonus payments and the completion of restructuring for loss-making subsidiaries will contribute to improvements in operating profit."
Heo pointed out that, in the process of bilateral tariff negotiations between countries, attention should be paid not only to tariff rates but also to the opening of agricultural and livestock markets. He highlighted the significance of the explicit opening of agricultural and livestock markets in Vietnam, Indonesia, and Japan, especially considering the previously closed nature of these markets from a food security perspective.
He said, "Given that the opening of agricultural and livestock markets is consistently mentioned during mutual tariff negotiations between the United States and its counterparts, the outlook for the U.S. livestock market appears increasingly positive. EasyBio is the only listed domestic company that can benefit from the restructuring of the global livestock supply chain centered on North America."
Heo emphasized, "The acquisition of Devenish marks the starting point for entering the U.S. market. The synergy with FMC and DFS, U.S. feed companies acquired by EasyHoldings, and the benefits from the growth of the U.S. livestock market, which will solidify EasyBio's status as a global supplier, are the company's biggest growth drivers."
He added, "This is because EasyBio is actively participating in the North American livestock value chain. Due to demand created by geopolitical issues, the supply volume is also expected to increase going forward."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
